• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Iranian Journal of Pharmaceutical Research
Articles in Press
Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Supplement
Issue Issue 1
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Shidfar, F., Rahideh, S., Rajab, A., Khandozi, N., Hosseini, S., Shidfar, S., Mojab, F. (2014). The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients. Iranian Journal of Pharmaceutical Research, 13(4), 1249-1255.
Farzad Shidfar; Seyedeh Tayebeh Rahideh; Asadollah Rajab; Nafiseh Khandozi; Sharieh Hosseini; Shahrzad Shidfar; Faraz Mojab. "The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients". Iranian Journal of Pharmaceutical Research, 13, 4, 2014, 1249-1255.
Shidfar, F., Rahideh, S., Rajab, A., Khandozi, N., Hosseini, S., Shidfar, S., Mojab, F. (2014). 'The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients', Iranian Journal of Pharmaceutical Research, 13(4), pp. 1249-1255.
Shidfar, F., Rahideh, S., Rajab, A., Khandozi, N., Hosseini, S., Shidfar, S., Mojab, F. The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients. Iranian Journal of Pharmaceutical Research, 2014; 13(4): 1249-1255.

The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients

Article 17, Volume 13, Issue 4, Autumn 2014, Page 1249-1255  XML PDF (943 K)
Document Type: Research article
Authors
Farzad Shidfar1; Seyedeh Tayebeh Rahideh 1; Asadollah Rajab2; Nafiseh Khandozi1; Sharieh Hosseini3; Shahrzad Shidfar4; Faraz Mojaborcid 5
1Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences
2Iranian Diabetes Association
3Islamic Azad University, Sari Branch
4University of Massachusetts, Worcester Memorial Hospital, Worcester
5School of Pharmacy, Shahid Beheshti University of Medical Sciences
Abstract
Sumac (Rhus coriaria L.) is used as an herbal remedy in traditional medicine. The aim of this study was to determine the effects of sumac (Rhus coriaria L.) on serum glycemic status, apolipoprotein (apo) B, apoA-I and total antioxidant capacity (TAC) in type 2 diabetic patients. This double blind randomized controlled clinical trial was conducted on 41 type 2 diabetic volunteers randomly assigned into 3g/day sumac powder (n=22) or placebo (n=19) groups over 3 months. Blood samples were collected before and after the intervention. Serum glucose and HbA1c were measured using enzymatic and turbidimetric inhibition immunoassay methods, respectively. ApoB, apoA-I and TAC were determined using turbidimetric immunoassay and spectrophotometric methods, respectively. There were significant decreases in serum glucose and HbA1c and also apoB levels at the end of study compared with initial values (P < 0.0001, P= 0.002 and P < 0.0001, respectively). Also, there was a significant difference in HbA1c and TAC levels between placebo and sumac groups at the end of study (P < 0.05). In sumac group, there were significant increase in apoA-I and TAC (P < 0.0001) compared with initial values. The mean of differences of serum glucose, HbA1c, apoB, apoA-I, apoB/apoA-I ratio and TAC between groups were significant (P < 0.05). In conclusion, these results showed the favorite effect of sumac consumption on serum glycemic status, apoB, apoA-I and TAC levels in in type 2 diabetic patients
Keywords
Sumac; glycemic status; apolipoprotein; total antioxidant capacity; Diabetes
Main Subjects
Drug quality control
Statistics
Article View: 8,708
PDF Download: 27,417
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.